Business News

Cytomos Secures £4 Million to Develop Spectroscopy Platform

August 14, 2023

Cytomos will use the £4 million in funding to develop its dielectric spectroscopy technology.

Novartis Finalizes Chinook Therapeutics Acquisition in Deal Worth Up to $3.5 Billion

August 11, 2023

Novartis has completed its acquisition of biopharma company Chinook Therapeutics.

Regeneron Pharmaceuticals to Acquire Decibel Therapeutics

August 10, 2023

The initial collaboration between the two companies began in 2017 with an extension announced in 2021.

iTolerance and Northway Biotech Form Manufacturing Pact for Fusion Protein

August 04, 2023

Under a manufacturing agreement, Northway Biotech will develop a manufacturing process for iTolerance’s fusion protein in development for regenerative therapy.

Biogen to Acquire Reata Pharmaceuticals for $7.3 Billion

August 01, 2023

Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.

AstraZeneca and Pfizer Ink $1 Billion Rare Disease Deal

August 01, 2023

AstraZeneca, via its subsidiary Alexion Pharmaceuticals, will purchase a portfolio of preclinical rare disease gene therapies from Pfizer in a deal worth up to $1 billion.

Biovian Invests €50 Million in Manufacturing Facility in Finland

July 28, 2023

The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.

Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership

July 27, 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

Roche and Alnylam Strike $2.8 Billion RNAi Deal

July 27, 2023

Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.

Sanofi and Recludix Enter STAT6 Inhibitor Partnership Worth More Than $1.3 Billion

July 24, 2023

Sanofi and Recludix Pharma’s deal centers on developing treatments for various immunological and inflammatory diseases.